Meyd-773

  1. Scientific compound or material? If so, what are its properties and applications?
  2. Technological product? If so, what are its features and uses?
  3. Research study or project? If so, what are the research questions and findings?

Cell viability was measured after 72 h treatment with MEYD‑773 (0.01–10 µM) using the CellTiter‑Glo luminescent assay (Promega). Apoptosis was quantified by Annexin V‑FITC/PI staining (BD Biosciences) and caspase‑3/7 activity (Caspase‑Glo, Promega).

How I Can Structure the Final Deliverable

The DLQSE’s twin reactors flickered to life, the exotic matter cores humming at a frequency of 2.73 × 10⁻⁶ Hz—a resonance that matched the quantum fluctuations of the slipstream field. The ship’s PSM hull began to emit a faint violet luminescence as the field generators aligned. MEYD-773

MEYD-773

is a Japanese adult video (JAV) production released on October 5, 2021 , under the "Meidi" (MEYD) label. Scientific compound or material

The Habitat Ring

– A rotating torus providing artificial gravity for the crew. It housed living quarters, research labs, hydroponic farms, and a small recreation complex. The ring’s rotation rate was modulated to counteract any residual shear forces from the slipstream, ensuring the crew experienced a stable 1 g environment. Cell viability was measured after 72 h treatment

Triple‑negative breast cancer (TNBC) accounts for ~15‑20 % of all breast cancers and is characterized by an aggressive clinical course, early metastasis, and a paucity of targeted therapies (1). Genomic analyses have highlighted the phosphatidylinositol‑3‑kinase (PI3K)/AKT/mTOR axis as a central driver of proliferation, survival, and chemoresistance in TNBC (2,3). While several pan‑class I PI3K inhibitors have entered clinical testing, dose‑limiting toxicities—particularly hyperglycemia, rash, and immune suppression—have limited their therapeutic window (4). Consequently, there is a critical need for next‑generation PI3K inhibitors with improved selectivity, oral bioavailability, and tumor‑specific activity.

One crisp autumn evening, under the light of a moon that seemed to glow with an ethereal intensity, Elara finally found herself standing before the shimmering portal of MEYD-773. The air around her vibrated with an otherworldly energy, and she could feel the weight of centuries of mystery emanating from the gateway.

At T‑00:03:00, Captain Kwon addressed the crew via the ship’s omnipresent holo‑array: